Human leukocyte antigen frequency in human high-grade gliomas: A case-control study in sicily

Neurosurgery

Volumn 64, Issue 6, 2009, Pages 1082-1088

  LaTorre, Domenico ^a   Maugeri, Rosario ^a   Angileri, Filippo F ^a   Pezzino, Gaetana ^b   Conti, Alfredo ^a   Cardali, Salvatore M ^a   Calisto, Amedeo ^a   Sciarrone, Giuseppe ^a   Misefari, Aldo ^b   Germanò, Antonino ^a   Tomasello, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Brain tumors; High Grade glioma; Human leukocyte antigen; Neoplasm; Tumor antigens

Indexed keywords

HLA A11 ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GLIOMA; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; SICILY;

EID: 68049090934     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000345946.35786.92     Document Type: Article

References (37)

1. Armstrong RM, Hanson CW: Familial gliomas. Neurology 19:1061-1063, 1969.
2. Ballerini C, Guerini FR, Rombolà G, Rosati E, Massacesi L, Ferrante P, Caputo D, Talamanca LF, Naldi P, Liguori M, Alizadeh M, Momigliano-Richiardi P, D'Alfonso S: HLA multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 150:178-185, 2004. (Pubitemid 38481662)
3. Burnet FM: The concept of immunological surveillance. Prog Exp Tumor Res 13:1-27, 1970.
4. Burt RD, Vaughan TL, McKnight B, Davis S, Beckmann AM, Smith AG, Nisperos B, Swanson GM, Berwick M: Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev 5:879-887, 1996. (Pubitemid 26382981)
5. Cao K, Chopek M, Fernández-Viña MA: High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP). Rev Immunogenet 1:177-208, 1999.
6. Chatzipetrou MA, Tarassi KE, Konstadoulakis MM, Pappas HE, Zafirellis KD, Athanassiades TE, Papadopoulos SA, Panousopoulos DG, Golematis BC, Papasteriades CA: Human leukocyte antigens as genetic markers in colorectal carcinoma. Dis Colon Rectum 42:66-70, 1999.
7. Chemke J, Katznelson D, Zucker G: Familial glioblastoma multiforme without neurofibromatosis. Am J Med Genet 21:731-735, 1985. (Pubitemid 15237655)
8. Concha A, Esteban F, Cabrera T, Ruiz-Cabello F, Garrido F: Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol 2:47-54, 1991.
9. Coulie PG, Hanagiri T, Takenoyama M: From tumor antigens to immunotherapy. Int J Clin Oncol 6:163-170, 2001.
10. de Moerloose P, Jeannet M, Martin-Achard A, de Tribolet N, Seiler R, Guanella N: HLA and glioma. Tissue Antigens 12:146-148, 1978.
11. Dunn GP, Old LJ, Schreiber RD: The three Es of cancer immunoediting. Annu Rev Immunol 22:329-360, 2004.
12. Frigerio S, Ciusani E, Pozzi A, Silvani A, Salmaggi A, Boiardi A: Tumor necrosis factor microsatellite polymorphism in Italian glioblastoma patients. Cancer Genet Cytogenet 109:172-174, 1999. (Pubitemid 29128363)
13. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL: Natural history of HLA expression during tumor development. Immunol Today 14:491-499, 1993. (Pubitemid 23301000)
14. Gonzalez-Gay MA, Garcia Porrua C, Hajeer AH: Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31:355-360, 2002. (Pubitemid 34734374)
15. Guerini FR, Agliardi C, Zanzottera M, Delbue S, Pagani E, Tinelli C, Boldorini R, Car PG, Veggiani C, Ferrante P: Human leukocyte antigens distribution analysis in North Italian brain glioma patients: An association with HLA-DRB1 14. J Neurooncol 77:213-217, 2005. (Pubitemid 44419758)
16. Hansen TH, Sachs DH: The major histocompatibility complex, in Paul WE (ed): Fundamental Immunology. New York, Raven Press, 1989, ed 2, p 445.
17. Hou TY, Chen HC, Chen CH, Chang DM, Liu FC, Lai JH: Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience. Intern Med J 37:749-752, 2007.
18. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR: HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 56:135-141, 2004. (Pubitemid 38916317)
19. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumor of the Central Nervous System. Berlin, Springer-Verlag, 1993, ed 2.
20. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-229, 2002. (Pubitemid 34212595)
21. Krul EJ, Schipper RF, Schreuder GM, Fleuren GJ, Kenter GG, Melief CJ: HLA and susceptibility to cervical neoplasia. Hum Immunol 60:337-342, 1999.
22. Luongo V, Pirozzi G, Caracò C, Errico S, de Angelis F, Celentano E, Paino F, Chiofalo MG, Luongo M, Mozzillo N, Lombardi ML: HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma. Tissue Antigens 64:84-87, 2004. (Pubitemid 38850374)
23. Machulla HK, Steinborn F, Schaaf A, Heidecke V, Rainov NG: Brian glioma and human leukocyte antigens (HLA) - Is there an association? J Neurooncol 52:253-261, 2001. (Pubitemid 33638525)
24. Manuelidis L: Genomic stability and instability in different neuroepithelial tumors: A role for chromosome structure? J Neurooncol 18:225-239, 1994.
25. McCarthy BJ, Lipton R, Nichol L: HLA-DQA1 and DQB1 alleles in Latino and African American children with diabetes mellitus. J Pediatr Endocrinol Metab 17:297-306, 2004. (Pubitemid 38923339)
26. Méndez R, Ruiz-Cabello F, Rodríguez T, Del Campo A, Paschen A, Schadendorf D, Garrido F: Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy. Cancer Immunol Immunother 56:88-94, 2007. (Pubitemid 44812450)
27. Nitta T, Ebato M, Sato K: Association of malignant glioma with the human leukocyte antigen, HLA-A24(9). Neurosurg Rev 17:211-215, 1994. (Pubitemid 24323105)
28. Ohtani M, Azuma T, Yamazaki S, Yamakawa A, Ito Y, Muramatsu A, Dojo M, Yamazaki Y, Kuriyama M: Association of the HLA-DRB1 gene locus with gastric adenocarcinoma in Japan. Dig Liver Dis 35:468-472, 2003. (Pubitemid 41070438)
29. Pardoll D: Does the immune system see tumors as foreign or self? Annu Rev Immunol 21:807-839, 2003.
30. Robinson MA, Kindt TJ: Major histocompatibility complex antigens and genes, in Paul WE (ed): Fundamental Immunology. New York, Raven Press, 1989, ed 2, p 489.
31. Romano PJ, Bartholomew M, Smith PJ, Kloszewski F, Stryker J, Houck J, Vesell ES: HLA antigens influence resistance to lung carcinoma. Hum Immunol 31:236-240, 1991.
32. Rosenberg SA: Progress in human tumor immunology and immunotherapy. Nature 411:380-384, 2001.
33. Sheen-Chen SM, Chou FF, Eng HL, Chen WJ: An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer. Surgery 116:510-515, 1994. (Pubitemid 24286777)
34. Takai N, Yoshida S, Hara N, Saito T, Kamoya K, Tanaka R: Investigation of HLA in patients with glioma [in Japanese]. No To Shinkei 38:741-745, 1986.
35. Tanaka Y, Koido S, Ohana M, Liu C, Gong J: Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells. J Immunol 174:1274-1280, 2005.
36. Vyakarnam A, Sidebottom D, Murad S, Underhill JA, Easterbrook PJ, Dalgleish AG, Peakman M: Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-Cell decline in human immunodeficiency virus infection. Immunology 112:136-142, 2004. (Pubitemid 38609831)
37. Younger AR, Amria S, Jeffrey WA, Mahdy AE, Goldstein OG, Norris JS, Haque A: HLA class II antigen presentation by prostate cancer cells. Prostate Cancer Prostatic Dis 11:334-341, 2008.